BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 19846694)

  • 1. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture.
    Saris DB; Vanlauwe J; Victor J; Almqvist KF; Verdonk R; Bellemans J; Luyten FP;
    Am J Sports Med; 2009 Nov; 37 Suppl 1():10S-19S. PubMed ID: 19846694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture.
    Saris DB; Vanlauwe J; Victor J; Haspl M; Bohnsack M; Fortems Y; Vandekerckhove B; Almqvist KF; Claes T; Handelberg F; Lagae K; van der Bauwhede J; Vandenneucker H; Yang KG; Jelic M; Verdonk R; Veulemans N; Bellemans J; Luyten FP
    Am J Sports Med; 2008 Feb; 36(2):235-46. PubMed ID: 18202295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters.
    Vanlauwe J; Saris DB; Victor J; Almqvist KF; Bellemans J; Luyten FP;
    Am J Sports Med; 2011 Dec; 39(12):2566-74. PubMed ID: 21908720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair of focal cartilage defects with scaffold-assisted autologous chondrocyte grafts: clinical and biomechanical results 48 months after transplantation.
    Kreuz PC; Müller S; Freymann U; Erggelet C; Niemeyer P; Kaps C; Hirschmüller A
    Am J Sports Med; 2011 Aug; 39(8):1697-705. PubMed ID: 21540360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized clinical study of osteochondral autologous transplantation versus microfracture for the treatment of osteochondritis dissecans in the knee joint in children.
    Gudas R; Simonaityte R; Cekanauskas E; Tamosiūnas R
    J Pediatr Orthop; 2009; 29(7):741-8. PubMed ID: 20104156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes.
    Gudas R; Gudaite A; Pocius A; Gudiene A; Cekanauskas E; Monastyreckiene E; Basevicius A
    Am J Sports Med; 2012 Nov; 40(11):2499-508. PubMed ID: 23024150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years.
    Crawford DC; DeBerardino TM; Williams RJ
    J Bone Joint Surg Am; 2012 Jun; 94(11):979-89. PubMed ID: 22637204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up.
    Cole BJ; Farr J; Winalski CS; Hosea T; Richmond J; Mandelbaum B; De Deyne PG
    Am J Sports Med; 2011 Jun; 39(6):1170-9. PubMed ID: 21460066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Articular cartilage treatment in high-level male soccer players: a prospective comparative study of arthroscopic second-generation autologous chondrocyte implantation versus microfracture.
    Kon E; Filardo G; Berruto M; Benazzo F; Zanon G; Della Villa S; Marcacci M
    Am J Sports Med; 2011 Dec; 39(12):2549-57. PubMed ID: 21900624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of full-thickness cartilage defects of the knee joint.
    Pestka JM; Bode G; Salzmann G; Südkamp NP; Niemeyer P
    Am J Sports Med; 2012 Feb; 40(2):325-31. PubMed ID: 22056348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial.
    Saris D; Price A; Widuchowski W; Bertrand-Marchand M; Caron J; Drogset JO; Emans P; Podskubka A; Tsuchida A; Kili S; Levine D; Brittberg M;
    Am J Sports Med; 2014 Jun; 42(6):1384-94. PubMed ID: 24714783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years.
    Kon E; Gobbi A; Filardo G; Delcogliano M; Zaffagnini S; Marcacci M
    Am J Sports Med; 2009 Jan; 37(1):33-41. PubMed ID: 19059899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of deep cartilage defects of the knee with autologous chondrocyte transplantation on a hyaluronic Acid ester scaffolds (Hyalograft C)].
    Podskubka A; Povýsil C; Kubes R; Sprindrich J; Sedlácek R
    Acta Chir Orthop Traumatol Cech; 2006 Aug; 73(4):251-63. PubMed ID: 17026884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and radiological outcomes 5 years after matrix-induced autologous chondrocyte implantation in patients with symptomatic, traumatic chondral defects.
    Marlovits S; Aldrian S; Wondrasch B; Zak L; Albrecht C; Welsch G; Trattnig S
    Am J Sports Med; 2012 Oct; 40(10):2273-80. PubMed ID: 22922521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical activity levels after characterized chondrocyte implantation versus microfracture in the knee and the relationship to objective functional outcome with 2-year follow-up.
    Van Assche D; Van Caspel D; Vanlauwe J; Bellemans J; Saris DB; Luyten FP; Staes F
    Am J Sports Med; 2009 Nov; 37 Suppl 1():42S-49S. PubMed ID: 19861694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing accelerated and traditional approaches to postoperative weightbearing rehabilitation after matrix-induced autologous chondrocyte implantation: findings at 5 years.
    Ebert JR; Fallon M; Zheng MH; Wood DJ; Ackland TR
    Am J Sports Med; 2012 Jul; 40(7):1527-37. PubMed ID: 22539536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations and treatment outcomes for patellofemoral articular cartilage defects with autologous chondrocyte implantation: prospective evaluation at average 4-year follow-up.
    Pascual-Garrido C; Slabaugh MA; L'Heureux DR; Friel NA; Cole BJ
    Am J Sports Med; 2009 Nov; 37 Suppl 1():33S-41S. PubMed ID: 19861699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study.
    Nejadnik H; Hui JH; Feng Choong EP; Tai BC; Lee EH
    Am J Sports Med; 2010 Jun; 38(6):1110-6. PubMed ID: 20392971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sex on the outcome of autologous chondrocyte implantation in chondral defects of the knee.
    Kreuz PC; Müller S; von Keudell A; Tischer T; Kaps C; Niemeyer P; Erggelet C
    Am J Sports Med; 2013 Jul; 41(7):1541-8. PubMed ID: 23729686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterized chondrocyte implantation in the patellofemoral joint: an up to 4-year follow-up of a prospective cohort of 38 patients.
    Vanlauwe JJ; Claes T; Van Assche D; Bellemans J; Luyten FP
    Am J Sports Med; 2012 Aug; 40(8):1799-807. PubMed ID: 22785604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.